iPACK Block vs. Periarticular Infiltration for TKA Pain Control
Postoperative Analgesic Outcomes of iPACK Block Versus Periarticular Infiltration in Total Knee Arthroplasty: A Retrospective Cohort Study
1 other identifier
observational
100
1 country
1
Brief Summary
This study aims to retrospectively compare two different multimodal analgesic techniques for pain management after total knee arthroplasty (TKA). The primary purpose is to evaluate whether a combination of two specific nerve blocks administered by an anesthesiologist (Femoral Triangle Block + iPACK block) resulted in superior postoperative pain control compared to a hybrid combination of a nerve block and a local infiltration administered by the surgeon (FTB + Periarticular Infiltration \[PAI\]). The hypothesis is that the FTB + iPACK combination is associated with a significant reduction in Numeric Rating Scale (NRS) pain scores with movement at 24 hours postoperatively. This is a retrospective, observational cohort study conducted at a single center, involving medical records of patients who underwent primary unilateral TKA. Data from patients who received either FTB + iPACK or FTB + PAI as part of their standard clinical care will be extracted and analyzed retrospectively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2025
CompletedFirst Posted
Study publicly available on registry
December 5, 2025
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
CompletedJune 1, 2026
May 1, 2026
Same day
November 16, 2025
May 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Pain Score with Movement at 24 Hours
Pain assessed via Numeric Rating Scale (NRS) during active movement (e.g., active knee flexion or straight leg raise). Scale: 0 (no pain) to 10 (worst pain imaginable).
24 and 48. hours postoperatively
Secondary Outcomes (6)
Postoperative Pain Scores (Time-Course)
Assessed at 6, 12, and 24 hours postoperatively
Time to First Rescue Analgesia
First 24 postoperative hours
Time Up to Go Test
Assessed at 24 hours
Straight Leg Raise
Postoperative 24. hour
Knee Range of Motion (ROM)
Baseline (Preoperative) and 24 hours postoperatively
- +1 more secondary outcomes
Study Arms (2)
FTB + iPACK Group
Patients who underwent primary unilateral TKA and received FTB + iPACK block as part of standard clinical care.
FTB + PAI Group
Patients who underwent primary unilateral TKA and received FTB + PAI as part of standard clinical care.
Interventions
Eligibility Criteria
The study population consists of adult patients who underwent elective, primary, unilateral total knee arthroplasty (TKA) under spinal anesthesia at Turgutlu State Hospital. Patient records and institutional registries will be reviewed retrospectively to identify eligible cases managed within a specific operational period (e.g., between December 2025 and May 2026). The cohort includes patients who received either an ultrasound-guided Femoral Triangle Block combined with an iPACK block or a hybrid combination of Femoral Triangle Block and surgeon-administered Periarticular Infiltration for postoperative analgesia as part of standard clinical care.
You may qualify if:
- American Society of Anesthesiologists (ASA) physical status II-III.
- Scheduled for elective, primary, unilateral total knee arthroplasty for osteoarthritis.
- Able to provide written informed consent.
You may not qualify if:
- Patient refusal to participate or contraindication to regional anesthesia.
- Known allergy to any study medications (local anesthetics, NSAIDs, tramadol, morphine, paracetamol).
- History of chronic opioid use (defined as daily use for \>3 months)
- Pre-existing peripheral neuropathy in the operative limb.
- Severe renal or hepatic insufficiency.
- Cognitive impairment preventing the use of pain scales or questionnaires.
- Revision or bilateral knee arthroplasty.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Turgutlu State Hospital+
Manisa, Manisa, 45000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aslan
Turgutlu State Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiologist
Study Record Dates
First Submitted
November 16, 2025
First Posted
December 5, 2025
Study Start
May 1, 2026
Primary Completion
May 1, 2026
Study Completion
August 1, 2026
Last Updated
June 1, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP, CSR
All the patient statistics